These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23253477)

  • 1. VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx.
    Ngok SP; Geyer R; Liu M; Kourtidis A; Agrawal S; Wu C; Seerapu HR; Lewis-Tuffin LJ; Moodie KL; Huveldt D; Marx R; Baraban JM; Storz P; Horowitz A; Anastasiadis PZ
    J Cell Biol; 2012 Dec; 199(7):1103-15. PubMed ID: 23253477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-mediated 14-3-3 protein binding regulates the function of the rho-specific guanine nucleotide exchange factor (RhoGEF) Syx.
    Ngok SP; Geyer R; Kourtidis A; Storz P; Anastasiadis PZ
    J Biol Chem; 2013 Mar; 288(9):6640-50. PubMed ID: 23335514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syx, a RhoA guanine exchange factor, is essential for angiogenesis in Vivo.
    Garnaas MK; Moodie KL; Liu ML; Samant GV; Li K; Marx R; Baraban JM; Horowitz A; Ramchandran R
    Circ Res; 2008 Sep; 103(7):710-6. PubMed ID: 18757825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab13-dependent trafficking of RhoA is required for directional migration and angiogenesis.
    Wu C; Agrawal S; Vasanji A; Drazba J; Sarkaria S; Xie J; Welch CM; Liu M; Anand-Apte B; Horowitz A
    J Biol Chem; 2011 Jul; 286(26):23511-20. PubMed ID: 21543326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TEM4 is a junctional Rho GEF required for cell-cell adhesion, monolayer integrity and barrier function.
    Ngok SP; Geyer R; Kourtidis A; Mitin N; Feathers R; Der C; Anastasiadis PZ
    J Cell Sci; 2013 Aug; 126(Pt 15):3271-7. PubMed ID: 23729734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A local VE-cadherin and Trio-based signaling complex stabilizes endothelial junctions through Rac1.
    Timmerman I; Heemskerk N; Kroon J; Schaefer A; van Rijssel J; Hoogenboezem M; van Unen J; Goedhart J; Gadella TW; Yin T; Wu Y; Huveneers S; van Buul JD
    J Cell Sci; 2015 Aug; 128(16):3041-54. PubMed ID: 26116572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Amot/Patj/Syx signaling complex spatially controls RhoA GTPase activity in migrating endothelial cells.
    Ernkvist M; Luna Persson N; Audebert S; Lecine P; Sinha I; Liu M; Schlueter M; Horowitz A; Aase K; Weide T; Borg JP; Majumdar A; Holmgren L
    Blood; 2009 Jan; 113(1):244-53. PubMed ID: 18824598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells.
    Kusuhara S; Fukushima Y; Fukuhara S; Jakt LM; Okada M; Shimizu Y; Hata M; Nishida K; Negi A; Hirashima M; Mochizuki N; Nishikawa S; Uemura A
    PLoS One; 2012; 7(9):e45858. PubMed ID: 23029280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VE-PTP inhibition stabilizes endothelial junctions by activating FGD5.
    Braun LJ; Zinnhardt M; Vockel M; Drexler HC; Peters K; Vestweber D
    EMBO Rep; 2019 Jul; 20(7):e47046. PubMed ID: 31267715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia.
    Gavard J; Patel V; Gutkind JS
    Dev Cell; 2008 Jan; 14(1):25-36. PubMed ID: 18194650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effect of angiopoietin-1 on VEGF-mediated disruption of endothelial cell-cell interactions requires activation of PKC beta.
    Wang Y; Pampou S; Fujikawa K; Varticovski L
    J Cell Physiol; 2004 Jan; 198(1):53-61. PubMed ID: 14584044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor-induced ArhGEF10 selectively activates RhoB contributing to human microvascular endothelial cell tight junction disruption.
    Khan A; Ni W; Lopez-Giraldez F; Kluger MS; Pober JS; Pierce RW
    FASEB J; 2021 Jun; 35(6):e21627. PubMed ID: 33948992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho GEFs in endothelial junctions: Effector selectivity and signaling integration determine junctional response.
    Ngok SP; Anastasiadis PZ
    Tissue Barriers; 2013 Dec; 1(5):e27132. PubMed ID: 24790803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RhoA GEF Syx is a target of Rnd3 and regulated via a Raf1-like ubiquitin-related domain.
    Goh LL; Manser E
    PLoS One; 2010 Aug; 5(8):e12409. PubMed ID: 20811643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rho guanine nucleotide exchange factor Syx regulates the balance of dia and ROCK activities to promote polarized-cancer-cell migration.
    Dachsel JC; Ngok SP; Lewis-Tuffin LJ; Kourtidis A; Geyer R; Johnston L; Feathers R; Anastasiadis PZ
    Mol Cell Biol; 2013 Dec; 33(24):4909-18. PubMed ID: 24126053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanine nucleotide exchange factor-H1 signaling is involved in lipopolysaccharide-induced endothelial barrier dysfunction.
    Zhou Z; Guo F; Dou Y; Tang J; Huan J
    Surgery; 2013 Sep; 154(3):621-31. PubMed ID: 23859306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production.
    Pizurki L; Zhou Z; Glynos K; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2003 May; 139(2):329-36. PubMed ID: 12770938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation.
    Post A; Pannekoek WJ; Ponsioen B; Vliem MJ; Bos JL
    Mol Cell Biol; 2015 Jul; 35(14):2495-502. PubMed ID: 25963656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGD5 mediates proangiogenic action of vascular endothelial growth factor in human vascular endothelial cells.
    Kurogane Y; Miyata M; Kubo Y; Nagamatsu Y; Kundu RK; Uemura A; Ishida T; Quertermous T; Hirata K; Rikitake Y
    Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):988-96. PubMed ID: 22328776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties.
    Satchell SC; Anderson KL; Mathieson PW
    J Am Soc Nephrol; 2004 Mar; 15(3):566-74. PubMed ID: 14978158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.